Fischer Medical Ventures Share Price
Small Cap | Chemicals | BSE: 524743
₹811.00 -37.65 (-4.44 %)
Last Updated: 02 May 2025 04:01 PM
Overview
Open (₹) 848.00
High (₹) 862.75
Low (₹) 800.00
Prev. Close (₹) 848.65
Volume 2,486
VWAP (₹) 841.41
ROCE (%) 2.64
Industry P/E 41.98
TTM P/E 2079.49
P/B Ratio 53.50
Market Cap (₹) Cr.5,174.31
Dividend Yield (%)--
EPS (₹) 1.08
ROE7.12%
Sales Growth (%) 11588.75
Profit Growth (%)-5,135.34
Day Range
862.75862.75
52 Week Range
454.35919.00
Historical Returns
Returns (6M)
27.95 %
Returns (1Y)
61.51 %
Returns (3Y)
1300.69 %
Returns (5Y)
1708.25 %
Returns (6M)
27.95 %
Returns (1Y)
61.51 %
Returns (3Y)
1300.69 %
Returns (5Y)
1708.25 %
SWOT Analysis
Technicals
Technical Rating
RSI 53.83
MFI 63.77
ATR 56.01
Commodity Channel Index 58.28
ROC125 22.44
ROC21 1.40
Williams %R -58.60
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 875.51 | 932.73 | 965.46 | 842.78 | 785.56 | 752.83 | 695.61 |
Week Ago | 829.94 | 854.97 | 874.94 | 809.97 | 784.94 | 764.97 | 739.94 |
Month Ago | 811.30 | 829.65 | 839.30 | 801.65 | 783.30 | 773.65 | 755.30 |
EMA & SMA
811.00
Current Price
Bullish Moving Averages
6
Bearish Moving Averages
14
5 Day 813.33
9 Day 819.21
10 Day 822.05
12 Day 828.82
14 Day 826.25
20 Day 823.64
26 Day 819.67
50 Day 782.86
100 Day 734.08
200 Day 686.14
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
ANAND MOHAN | bulk | Sell | 10th Apr, 2023 | ₹79.80 | 1,258 | BSE |
KETAN RASHIKLAL DOSHI | bulk | Buy | 30th Jun, 2022 | ₹66.60 | 900 | BSE |
KIRTAN JITENDRA BHAI PATEL | bulk | Buy | 17th Jun, 2022 | ₹79.97 | 996 | BSE |
RAVINDRADADAJIJILTE | bulk | Sell | 27th Dec, 2021 | ₹93.27 | 973 | BSE |
MOHAMMADZAHIDHUSSAIN | bulk | Buy | 27th Dec, 2021 | ₹93.20 | 1,000 | BSE |
ARUNKUMAR | bulk | Buy | 23rd Aug, 2021 | ₹90.07 | 932 | BSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
9th Apr, 2025 | Nikita Sanjay Jain | Acquisition | ₹33.20 | 4,50,000 | BSE |
9th Apr, 2025 | Crishi Sanjay Jain | Acquisition | ₹33.20 | 4,50,000 | BSE |
20th Feb, 2025 | Time Medical International Ventures Pte Ltd | Acquisition | ₹58.50 | 23,00,000 | BSE |
20th Feb, 2025 | Shankar Varadharajan | Acquisition | ₹58.50 | 17,00,000 | BSE |
27th Jan, 2024 | Nikita Sanjay Jain | Acquisition | ₹8.30 | 4,50,000 | BSE |
27th Jan, 2024 | Crishi Sanjay Jain | Acquisition | ₹8.30 | 4,50,000 | BSE |
27th Jan, 2024 | Sanjay Jain HUF | Acquisition | ₹33.20 | 2,00,000 | BSE |
Corporate Actions
No corporate actions available.
Announcements
Date | Source | Detail |
---|---|---|
30th Apr, 2025 | BSE India | <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Fischer Medical Ventures Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L86900MH1993PLC288371</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>Nil</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=''float:left;''> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. YES</div> <br/><br/><br/> <div style=''float:left;''> Name of the Company Secretary: ARAVINDKUMAR VENKATASUBRAMANIAN <br/> Designation: COMPANY SECRETARY <br/> EmailId: cs@fischermv.com</div> <div ''style=float:left;margin-left:50px;''> Name of the Chief Financial Officer: VIVEK BALASUBRAMANAN <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: vivek.b@fischermv.com</div> </div> <div> <br/> Date: 30/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div> |
23rd Apr, 2025 | BSE India | Intimation by Material Subsidiary on the Investment |
23rd Apr, 2025 | BSE India | Fischer Medical Ventures Ltd has informed the exchange on receipt of Central Government Approval for appointment of Managing Director |
21st Apr, 2025 | BSE India | Update from Material Subsidiary on its proposed investment |
21st Apr, 2025 | BSE India | Fischer Medical Ventures Limited has informed the exchange on approval for proposed investment as detailed in the annexures to this announcement |
10th Apr, 2025 | BSE India | Please find attached file |
9th Apr, 2025 | BSE India | Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on creation of ISIN with NSDL |
9th Apr, 2025 | BSE India | Fischer Medical Ventures Limited has allotted 10,50,000 equity shares upon conversion of convertible warrants issued on a preferential basis to non-promoter public category. |
9th Apr, 2025 | BSE India | Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on the compliance of Certificate under Regulation 74(5) of SEBI DP Regulations |
7th Apr, 2025 | BSE India | Intimation about Investment in Material Subsidiary |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Others | Inter-alia, to consider 1. Appointment of Ms. Jaya Ankur Singhania as Independent Director. 2. Notice of Postal Ballot with explanatory statements and other related matter. 3. Other business matters. | 25th Mar, 2025 | 26th Mar, 2025 |
Quarterly Results | -- | 10th Feb, 2025 | 14th Feb, 2025 |
Others | Inter-alia, to consider 1. The withdrawal of the proposed preferential issue. 2. Notice for EGM. 3. To appoint Mr. Nuren Lodaya Practicing Company Secretary. 4. Other business matters. | 31st Dec, 2024 | 3rd Jan, 2025 |
Quarterly Results | -- | 6th Nov, 2024 | 13th Nov, 2024 |
Quarterly Results & Preferential issue | -- | 12th Aug, 2024 | 14th Aug, 2024 |
Audited Results | -- | 23rd May, 2024 | 30th May, 2024 |
Others | -- | 1st May, 2024 | 4th May, 2024 |
Quarterly Results | -- | 6th Feb, 2024 | 12th Feb, 2024 |
Others | Inter alia, 1. The proposal for fund raising by way of preferential issue / private placement of securities for cash / other than cash, including determination of Issue Price. | 13th Dec, 2023 | 15th Dec, 2023 |
Quarterly Results | -- | 26th Oct, 2023 | 1st Nov, 2023 |
Share Holding Pattern
Owner Name | Mar, 2025 | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 |
---|---|---|---|---|---|
Promoter Group | 62.81% | 74.91% | 0% | 0% | 0% |
Foreign Institutions + | 5.23% | 5.07% | 0% | 0% | 0% |
Domestic Institutions + | 1.44% | 1.68% | 0% | 0% | 0% |
Government | 0% | 0% | 0% | 0% | 0% |
Public | 30.52% | 18.34% | 100% | 100% | 100% |
Others | 0% | 0% | 0% | 0% | 0% |
About Fischer Medical Ventures
Fischer Medical Ventures is a Public Limited Listed company incorporated on 22/03/1993 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24231MH1993PLC288371 and registration number is 288371. Currently Company is involved in the business activities of Wholesale of scientific, medical and surgical machinery and equipment. Company’s Total Operating Revenue is Rs. 11.53 Cr. and Equity Capital is Rs. 53.50 Cr. for the Year ended 31/03/2024.
Parent Organisation
Not Applicable
Founded
1993
Managing Director
Mr. Ravindran Govindan
NSE Symbol
--
Fischer Medical Ventures Management
Name | Designation |
---|---|
Mr. Ravindran Govindan | Chairman & Managing Director |
Mr. Jeena Dineshchandra Suthar | Independent Director |
Mr. Sanjay Jayantilal Jain | Independent Director |
Mr. Svetlana Rao | Whole Time Executive Director |
Mr. Khairy Jamaluddin Abu Bakkar | Independent Director |
Mr. Jacob Thomas | Independent Director |
Mr. Roberto M Pagdanganan | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Deepak Nitrite | ₹26,400.24 | ₹1,989.60 ₹1,935.60(2.79%) | ₹1,780.500 - ₹3,168.650 |
Archean Chemical Industries | ₹7,742.62 | ₹604.65 ₹627.30(-3.61%) | ₹409.000 - ₹831.000 |
Fischer Medical Ventures | ₹5,414.52 | ₹811.00 ₹848.65(-4.44%) | ₹454.350 - ₹919.000 |
Tanfac Industries | ₹2,877.44 | ₹2,840.00 ₹2,884.65(-1.55%) | ₹1,875.650 - ₹3,970.000 |
Vishnu Chemicals | ₹2,861.57 | ₹424.80 ₹425.10(-0.07%) | ₹281.000 - ₹562.000 |
FAQs on Fischer Medical Ventures
What is the share price of Fischer Medical Ventures?
The share price of Fischer Medical Ventures on 2nd May, 2025 is ₹ 811.00.
What is 52W high and 52W low share price of Fischer Medical Ventures?
The highest and lowest 52W share prices of Fischer Medical Ventures are ₹ 919.000 and ₹ 454.350
What is the market cap of Fischer Medical Ventures?
The market capitalization of Fischer Medical Ventures as of 2nd May, 2025 is ₹ 5,174.31 Crores
What is the P/E ratio of Fischer Medical Ventures?
The current P/E ratio of Fischer Medical Ventures as of 2nd May, 2025 is 41.98
What is the PB ratio of Fischer Medical Ventures?
The PB ratio of Fischer Medical Ventures as of 2nd May, 2025 is 53.50
Top Gainers
₹78.00
₹65.00 (0.20%)
₹121.03
₹100.86 (0.20%)
₹13.15
₹11.00 (0.20%)
₹1.88
₹1.57 (0.20%)
Top Losers
₹107.95
₹123.00 (-0.12%)
₹0.50
₹0.56 (-0.11%)
₹24.55
₹28.11 (-0.13%)
₹3.34
₹3.80 (-0.12%)
Market Indices
Sensex
₹80,242.24
₹80,288.38 (0.00%)